{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:57:42Z","timestamp":1789084662086,"version":"build-2803163510"},"reference-count":46,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.3960\/jslrt.18011","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T18:29:44Z","timestamp":1533666584000},"page":"107-121","source":"Crossref","is-referenced-by-count":15,"title":["The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1\u2013associated myelopathy (HAM) \/ atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation"],"prefix":"10.3960","volume":"58","author":[{"given":"Noriaki","family":"Kawano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Toyofuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soushi","family":"Terasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenobu","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Marutsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Taylor GP. Human T-lymphotropic virus type 1 infection and solid organ transplantation. Rev Med Virol. 2018; 28: e1970.","DOI":"10.1002\/rmv.1970"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Miyoshi H, Ohshima K. Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia\/lymphoma in Japan. Int J Hematol. 2018; 107: 420-427.","DOI":"10.1007\/s12185-018-2430-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kogure Y, Kataoka K. Genetic alterations in adult T-cell leukemia\/lymphoma. Cancer Sci. 2017; 108: 1719-1725.","DOI":"10.1111\/cas.13303"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Osame M, Usuku K, Izumo S <i>et al.<\/i> HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986; 327: 1031-1032.","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Yamano Y, Coler-Reilly A. HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM\/TSP. J Neuroimmunol. 2017; 304: 51-55.","DOI":"10.1016\/j.jneuroim.2016.08.012"},{"key":"6","unstructured":"6 Zanke BW, Rush DN, Jeffery JR <i>et al.<\/i> HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient. Transplantation. 1989; 48: 695-697."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tsurumi H, Tani K, Tsuruta T <i>et al.<\/i> Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol. 1992; 41: 292-294.","DOI":"10.1002\/ajh.2830410414"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Jenks PJ, Barrett WY, Raftery MJ <i>et al.<\/i> Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia\/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis. 1995; 21: 992-993.","DOI":"10.1093\/clinids\/21.4.992"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Williams NP, Buchner LM, Shah DJ <i>et al.<\/i> Adult T-cell leukemia\/lymphoma in a renal transplant recipient: an opportunistic occurrence. Am J Nephrol. 1994; 14: 226-229.","DOI":"10.1159\/000168722"},{"key":"10","unstructured":"10 Mori J, Kamiryo Y, Yano S <i>et al.<\/i> Adult T-cell leukemia following ABO incompatible renal transplant patients in Japan. Renal Transplantation Vascular Surgery. 2000; 12: 137-141."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hoshida Y, Li T, Dong Z <i>et al.<\/i> Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer. 2001; 91: 869-875.","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ichikawa Y, Iida M, Ebisui C <i>et al.<\/i> A case study of adult t-cell lymphoma in a kidney transplant patient. Transplant Proc. 2000; 32: 1982-1983.","DOI":"10.1016\/S0041-1345(00)01521-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kawano N, Shimoda K, Ishikawa F <i>et al.<\/i> Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation. 2006; 82: 840-843.","DOI":"10.1097\/01.tp.0000235186.30113.c7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Yoshizumi T, Shirabe K, Ikegami T <i>et al.<\/i> Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant. 2012; 12: 1479-1485.","DOI":"10.1111\/j.1600-6143.2012.04037.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Yoshizumi T, Takada Y, Shirabe K <i>et al.<\/i> Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan. J Hepatobiliary Pancreat Sci. 2016; 23: 333-341.","DOI":"10.1002\/jhbp.345"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Nakamura N, Tamaru S, Ohshima K <i>et al.<\/i> Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc. 2005; 37: 1779-1782.","DOI":"10.1016\/j.transproceed.2005.03.132"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Tamaki H, Matsuoka M. Donor-derived T-cell leukemia after bone marrow transplantation. N Engl J Med. 2006; 354: 1758-1759.","DOI":"10.1056\/NEJMc053295"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nakamizo A, Akagi Y, Amano T <i>et al.<\/i> Donor-derived adult T-cell leukaemia. Lancet. 2011; 377: 1124.","DOI":"10.1016\/S0140-6736(11)60315-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kitamura N, Nakanishi T, Yoshida Y <i>et al.<\/i> HTLV-I\u2013associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells. Blood. 2017; 130: 84-86.","DOI":"10.1182\/blood-2016-11-749820"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Glowacka I, Korn K, Potthoff SA <i>et al.<\/i> Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor. Clin Infect Dis. 2013; 57: 1417-1424.","DOI":"10.1093\/cid\/cit545"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kawamata T, Ohno N, Sato K <i>et al.<\/i> A case of post-transplant adult T-cell leukemia\/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy. Springerplus. 2014; 3: 581.","DOI":"10.1186\/2193-1801-3-581"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Nagamine Y, Hayashi T, Kato Y <i>et al.<\/i> Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation. Intern Med. 2015; 54: 75-78.","DOI":"10.2169\/internalmedicine.54.2950"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ramanan P, Deziel PJ, Norby SM <i>et al.<\/i> Donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient--case report and literature review. Am J Transplant. 2014; 14: 2417-2421.","DOI":"10.1111\/ajt.12849"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Nakatsuji Y, Sugai F, Watanabe S <i>et al.<\/i> HTLV-I-associated myelopathy manifested after renal transplantation. J Neurol Sci. 2000; 177: 154-156.","DOI":"10.1016\/S0022-510X(00)00332-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kuroda Y, Takashima H, Yukitake M <i>et al.<\/i> Development of HTLV-I-associated myelopathy after blood transfusion in a patient with aplastic anemia and a recipient of a renal transplant. J Neurol Sci. 1992; 109: 196-199.","DOI":"10.1016\/0022-510X(92)90168-K"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Inose Y, Akiyama S, Mochizuki A <i>et al.<\/i> A case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation. Rinsho Shinkeigaku. 2010; 50: 241-245.","DOI":"10.5692\/clinicalneurol.50.241"},{"key":"27","unstructured":"27 Kuroki N, Kin M, Tateishi T. Rinsho Shinkeigaku. 2007; 48: 222 [in Japanese]."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Toro C, Rod\u00e9s B, Poveda E <i>et al.<\/i> Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation. 2003; 75: 102-104.","DOI":"10.1097\/00007890-200301150-00019"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Imirizaldu JJZ, Gomez Esteban JC, Rouco Axpe I <i>et al.<\/i> Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry. 2003; 74: 1080-1084.","DOI":"10.1136\/jnnp.74.8.1080"},{"key":"30","unstructured":"30 Shintani Y, Napou Y, Fujii R <i>et al.<\/i> One case of HAM after cadaveric renal transplantation. Ishoku. 2001; 36: 286."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Soyama A, Eguchi S, Takatsuki M <i>et al.<\/i> Human T-cell leukemia virus type I\u2013associated myelopathy following living-donor liver transplantation. Liver Transpl. 2008; 14: 647-650.","DOI":"10.1002\/lt.21414"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Ozden S, Seilhean D, Gessain A <i>et al.<\/i> Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient. Clin Infect Dis. 2002; 34: 855-860.","DOI":"10.1086\/338868"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Narukawa N, Shiizaki K, Kitabata Y <i>et al.<\/i> Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy. Ther Apher Dial. 2001; 5: 491-493.","DOI":"10.1046\/j.1526-0968.2001.00398.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kawano N, Kuriyama T, Yoshida S <i>et al.<\/i> The impact of a humanized CCR4 antibody (Mogamulizumab) on patients with aggressive-type adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation. J Clin Exp Hematop. 2017; 56: 135-144.","DOI":"10.3960\/jslrt.56.135"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Nagafuji K, Miyamoto T, Eto T <i>et al.<\/i> Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study). J Hematol Oncol. 2013; 6: 14.","DOI":"10.1186\/1756-8722-6-14"},{"key":"36","unstructured":"36 Terasaka S, Kitada H, Okabe Y <i>et al.<\/i> Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients. Exp Clin Transplant. 2014; 12: 227-232."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Nagle SJ, Reshef R, Tsai DE. Posttransplant lymphoproliferative disorder in solid organ and hematopoietic stem cell transplantation. Clin Chest Med. 2017; 38: 771-783.","DOI":"10.1016\/j.ccm.2017.08.001"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Morris J, Smith C, Streicher A <i>et al.<\/i> A rare presentation of isolated CNS posttransplantation lymphoproliferative disorder. Case Rep Oncol Med. 2017; 2017: 1-5.","DOI":"10.1155\/2017\/7269147"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Dotti G, Fiocchi R, Motta T <i>et al.<\/i> Lymphomas occurring late after solid-organ transplantation. Transplantation. 2002; 74: 1095-1102.","DOI":"10.1097\/00007890-200210270-00007"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Caillard S, Porcher R, Provot F <i>et al.<\/i> Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol. 2013; 31: 1302-1309.","DOI":"10.1200\/JCO.2012.43.2344"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Choquet S, Trappe R, Leblond V <i>et al.<\/i> CHOP-21 for the treatment of post-transplant lymphoproliferative disorders following solid organ transplantation. Haematologica. 2007; 92: 273-274.","DOI":"10.3324\/haematol.10595"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Choquet S, Oertel S, LeBlond V <i>et al.<\/i> Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution. Ann Hematol. 2007; 86: 599-607.","DOI":"10.1007\/s00277-007-0298-2"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Trappe RU, Choquet S, Reinke P <i>et al.<\/i> Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab. Transplantation. 2007; 84: 1708-1712.","DOI":"10.1097\/01.tp.0000295987.12996.19"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Trappe R, Oertel S, Leblond V <i>et al.<\/i>. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012; 13: 196-206.","DOI":"10.1016\/S1470-2045(11)70300-X"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Gross TG, Bucuvalas JC, Park JR <i>et al.<\/i> Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol. 2005; 23: 6481-6488.","DOI":"10.1200\/JCO.2005.08.074"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Dierickx D, Tousseyn T, Gheysens O. How I treat posttransplant lymphoproliferative disorders. Blood. 2015; 126: 2274-2283.","DOI":"10.1182\/blood-2015-05-615872"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/3\/58_18011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T20:14:57Z","timestamp":1571688897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/3\/58_18011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.18011","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}